• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平药代动力学和药效学的年龄相关性变化。

Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.

作者信息

Robertson D R, Waller D G, Renwick A G, George C F

机构信息

Clinical Pharmacology Group, Southampton General Hospital.

出版信息

Br J Clin Pharmacol. 1988 Mar;25(3):297-305. doi: 10.1111/j.1365-2125.1988.tb03307.x.

DOI:10.1111/j.1365-2125.1988.tb03307.x
PMID:3358895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1386353/
Abstract
  1. The effects of age on the pharmacology of nifedipine were investigated in 11 young and six elderly normotensive volunteers. 2. Following 2.5 mg of nifedipine i.v. the plasma clearance of nifedipine was 348 +/- 83 (s.d.) ml min-1 in the elderly compared with 519 +/- 125 ml min-1 in the young (P less than 0.05) and the AUC in the elderly was significantly greater at 125 +/- 28 ng ml-1 h compared with 83.9 +/- 19 ng ml-1 h (P less than 0.05). The Vss was similar in both age groups. 3. Following 10 mg oral sustained release nifedipine the AUC was 281 +/- 64 ng ml-1 h in the elderly compared with 136 +/- 56 ng ml-1 h in the young (P less than 0.002) and Cmax in the elderly was significantly greater at 36.8 +/- 11.8 ng ml-1 compared with 22.3 +/- 5.8 ng ml-1 (P less than 0.05). The trend towards an increased bioavailability in elderly subjects (36%) was supported by a significantly lower nitropyridine metabolite/nifedipine ratio in the elderly. 4. Absorption rate limited kinetics of the sustained release formulation were indicated by the prolonged t1/2 compared with i.v. administration. In the elderly t1/2 (oral) was significantly greater than in the young (elderly 6.7 +/- 2.2 h, young 3.8 +/- 1.4 h, P less than 0.05). 5. Haemodynamic changes in the young were confined to a tachycardia following i.v. administration. In the elderly, supine BP fell significantly following both oral and i.v. nifedipine while the heart rate remained unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 在11名年轻和6名老年血压正常的志愿者中研究了年龄对硝苯地平药理学的影响。2. 静脉注射2.5毫克硝苯地平后,老年组硝苯地平的血浆清除率为348±83(标准差)毫升/分钟,而年轻组为519±125毫升/分钟(P<0.05),老年组的AUC显著更高,为125±28纳克/毫升·小时,而年轻组为83.9±19纳克/毫升·小时(P<0.05)。两组的稳态分布容积相似。3. 口服10毫克缓释硝苯地平后,老年组的AUC为281±64纳克/毫升·小时,而年轻组为136±56纳克/毫升·小时(P<0.002),老年组的Cmax显著更高,为36.8±11.8纳克/毫升,而年轻组为22.3±5.8纳克/毫升(P<0.05)。老年受试者生物利用度增加的趋势(36%)得到老年组中显著更低的硝基吡啶代谢物/硝苯地平比值的支持。4. 与静脉给药相比,缓释制剂的吸收速率限制动力学表现为t1/2延长。老年组的t1/2(口服)显著长于年轻组(老年组6.7±2.2小时,年轻组3.8±1.4小时,P<0.05)。5. 年轻组的血流动力学变化仅限于静脉给药后的心动过速。在老年组中,口服和静脉注射硝苯地平后仰卧位血压均显著下降,而心率保持不变。(摘要截短于250字)

相似文献

1
Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.硝苯地平药代动力学和药效学的年龄相关性变化。
Br J Clin Pharmacol. 1988 Mar;25(3):297-305. doi: 10.1111/j.1365-2125.1988.tb03307.x.
2
Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.硝苯地平在健康志愿者中不同给药途径的生物利用度和药代动力学。
Arch Invest Med (Mex). 1989 Apr-Jun;20(2):129-35.
3
Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
Drugs Exp Clin Res. 2005;31(3):115-21.
4
Nifedipine: kinetics and dynamics in healthy subjects.硝苯地平:健康受试者的动力学与动态变化
Clin Pharmacol Ther. 1984 Jun;35(6):742-9. doi: 10.1038/clpt.1984.105.
5
Factors affecting the absolute bioavailability of nifedipine.影响硝苯地平绝对生物利用度的因素。
Br J Clin Pharmacol. 1995 Jul;40(1):51-8. doi: 10.1111/j.1365-2125.1995.tb04534.x.
6
The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.年龄对单独使用左旋多巴以及在卡比多巴存在情况下左旋多巴药代动力学的影响。
Br J Clin Pharmacol. 1989 Jul;28(1):61-9. doi: 10.1111/j.1365-2125.1989.tb03506.x.
7
The pharmacokinetics of oral nifedipine--a population study.口服硝苯地平的药代动力学——一项群体研究。
Br J Clin Pharmacol. 1988 Jun;25(6):701-8. doi: 10.1111/j.1365-2125.1988.tb05256.x.
8
Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
Braz J Med Biol Res. 1992;25(4):385-91.
9
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.硝苯地平:肾功能对药代动力学/血流动力学关系的影响。
Clin Pharmacol Ther. 1985 May;37(5):563-74. doi: 10.1038/clpt.1985.89.
10
The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.缓释硝苯地平在志愿者长期给药期间的生物利用度和药代动力学。
Br J Clin Pharmacol. 1986 Apr;21(4):385-8. doi: 10.1111/j.1365-2125.1986.tb05211.x.

引用本文的文献

1
Deterioration of preexisting myoclonus following nifedipine use in parkinsonian syndrome: A case report.帕金森综合征患者使用硝苯地平后原有肌阵挛加重:一例报告。
eNeurologicalSci. 2024 Dec 15;38:100545. doi: 10.1016/j.ensci.2024.100545. eCollection 2025 Mar.
2
Age-related modifications in CYP-dependent drug metabolism: role of stress.与年龄相关的 CYP 依赖性药物代谢的改变:应激的作用。
Front Endocrinol (Lausanne). 2023 May 24;14:1143835. doi: 10.3389/fendo.2023.1143835. eCollection 2023.
3
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions.CDK4/6 抑制剂在乳腺癌治疗中的作用:与药物、基因和病理生理状况的潜在相互作用。
Int J Mol Sci. 2020 Sep 1;21(17):6350. doi: 10.3390/ijms21176350.
4
Senescence and the Impact on Biodistribution of Different Nanosystems: the Discrepancy on Tissue Deposition of Graphene Quantum Dots, Polycaprolactone Nanoparticle and Magnetic Mesoporous Silica Nanoparticles in Young and Elder Animals.衰老对不同纳米系统生物分布的影响:年轻和老年动物组织中石墨烯量子点、聚己内酯纳米颗粒和磁性介孔硅纳米颗粒的沉积差异。
Pharm Res. 2020 Jan 22;37(3):40. doi: 10.1007/s11095-019-2754-9.
5
Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.描述人口老龄化的知识库,用于为考虑到解剖学、生理学和生物学年龄相关变化的基于生理学的药代动力学模型提供信息。
Clin Pharmacokinet. 2019 Apr;58(4):483-501. doi: 10.1007/s40262-018-0709-7.
6
A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.一种基于生理学的药代动力学模型,用于预测高蛋白结合药物的药代动力学以及血浆蛋白结合误差的影响。
Biopharm Drug Dispos. 2016 Apr;37(3):123-41. doi: 10.1002/bdd.1996.
7
Special population considerations and regulatory affairs for clinical research.临床研究的特殊人群考量与监管事务
Clin Res Regul Aff. 2015;32(2):47-56. doi: 10.3109/10601333.2015.1001900.
8
Treating older people.治疗老年人。
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:53-7. doi: 10.1007/s00228-013-1489-5. Epub 2013 May 3.
9
Progesterone blocks multiple routes of ion flux.孕激素阻断多种离子流途径。
Mol Cell Neurosci. 2011 Oct;48(2):137-41. doi: 10.1016/j.mcn.2011.07.002. Epub 2011 Jul 19.
10
Beers-Fick criteria and drugs available through the Farmácia Dose Certa program.《Beers - Fick标准》以及通过“精准剂量药房”计划可获取的药物。
Sao Paulo Med J. 2011 Jan 6;129(1):17-22. doi: 10.1590/s1516-31802011000100004.

本文引用的文献

1
Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow.用酚四溴酞磺酸钠法测定人体内脏血流量:外周血浆酚四溴酞磺酸钠水平与计算血流量的关系。
J Lab Clin Med. 1950 Jun;35(6):923-32.
2
THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN.年龄增长对人体外周血流分布的影响。
J Am Geriatr Soc. 1965 Mar;13:192-8. doi: 10.1111/j.1532-5415.1965.tb02665.x.
3
Studies of basal and peak acid output with an augmented histamine test.通过增强组胺试验对基础胃酸分泌量和最大胃酸分泌量的研究。
Gut. 1963 Jun;4(2):136-44. doi: 10.1136/gut.4.2.136.
4
Drug therapy: drug disposition in old age.药物治疗:老年人的药物处置
N Engl J Med. 1982 May 6;306(18):1081-8. doi: 10.1056/NEJM198205063061804.
5
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.硝苯地平在正常受试者单次静脉注射和口服后的动力学及生物利用度。
J Clin Pharmacol. 1983 Apr;23(4):161-70. doi: 10.1002/j.1552-4604.1983.tb02720.x.
6
Pharmacokinetics and metabolism of nifedipine.硝苯地平的药代动力学与代谢
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II18-24. doi: 10.1161/01.hyp.5.4_pt_2.ii18.
7
Nifedipine: kinetics and dynamics in healthy subjects.硝苯地平:健康受试者的动力学与动态变化
Clin Pharmacol Ther. 1984 Jun;35(6):742-9. doi: 10.1038/clpt.1984.105.
8
Gastrointestinal and liver function of old age.老年人的胃肠功能与肝功能
Clin Gastroenterol. 1983 Sep;12(3):671-91.
9
The first pass metabolism of nifedipine in man.硝苯地平在人体中的首过代谢。
Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x.
10
Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system.使用渗透系统直肠输注硝苯地平至稳态时的动力学和动态变化。
Clin Pharmacol Ther. 1984 Sep;36(3):396-401. doi: 10.1038/clpt.1984.194.